Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Concert Pharmaceuticals Company Profile (NASDAQ:CNCE)

Consensus Ratings for Concert Pharmaceuticals (NASDAQ:CNCE) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $22.50 (73.61% upside)

Analysts' Ratings History for Concert Pharmaceuticals (NASDAQ:CNCE)
Show:
DateFirmActionRatingPrice TargetDetailsShare
11/12/2014Roth CapitalLower Price TargetBuy$28.00 -> $21.00ViewTweet This Rating  Share This Rating on StockTwits
7/8/2014Roth CapitalReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
6/26/2014Ladenburg ThalmannInitiated CoverageBuy$24.00ViewTweet This Rating  Share This Rating on StockTwits
5/29/2014Roth CapitalInitiated CoverageBuy$28.00ViewTweet This Rating  Share This Rating on StockTwits
3/19/2014Roth CapitalInitiated CoverageBuy$28.00ViewTweet This Rating  Share This Rating on StockTwits
3/10/2014Wells Fargo & Co.Initiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
3/10/2014JMP SecuritiesInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/23/2012 forward)